CHAIRMAN OF THE BOARD
Ulrik Spork is director of SporCon Lifescience Advisors IVS and Salient Pharma, and chairman of the board of Practio ApS, MedTrace A/S and Technolution A/S. In addition he is a member of the board of Statumanu and a member of VF Ventures advisory board.
For many years and up until 2015, Ulrik Spork has been associated with Novo A/S, as Head of Venture Investments, Senior Partner i Novo Ventures, Managing Partner i Novo Growth Equity and recently Managing Partner for Large Investments. He has previously been a board member and chairman of the venture- and capital funds’ organization DVCA.